Fritextsökning
Artiklar per år
Innehållstyper
-
Life Science Sweden heads to the Oresund region! ‒ Hello there Michael Linnell
Life Science Sweden’s The Future of Swedish Danish Life Science and New Updates in Drug Formulation & Bioavailability meetings are coming up soon. We asked Michael Linnell, project manager for Life Science Sweden’s event portfolio, a few short questions.
-
Life Science Sweden beger sig till Öresundsregionen! – Hallå där Michael Linnell
Snart är det dags för Life Science Swedens möten The Future of Swedish Danish Life Science och New Updates in Drug Formulation & Bioavailability. Vi ställde ett par snabba frågor till Michael Linnell, projektledare för Life Science Swedens eventportfölj.
-
Double up for Korbinian Löbmann
This year, Korbinian Löbmann will moderate the New Updates in Drug Formulation & Bioavailability meeting in Copenhagen for the fifth time. Furthermore, he will also moderate The Future of Swedish & Danish Life Science congress in Lund for the first time.
-
CROs in drug development: "We use our expertise to speed up the process
Consultancy firms have become an increasingly important part of drug development. “It’s a trend and a business model that works, and we see no indication that it will change,” says Helena Lüning of the industry organisation ASCRO.
-
Why the world renown researcher Marc Tessier-Lavigne resigns as Stanford´s president
In mid-summer, neuroscientist Marc Tessier-Lavigne announced his resignation as President of Stanford following allegations of manipulated study data. According to the reporter Theo Baker, who first reported the story, Tessier-Lavigne “rewarded the winners and punished the losers”. Here is the background of the story which has shaken the American scientific community over the summer.
-
Glad sommar! – och chefredaktörens lästips
Life Science Swedens chefredaktör sammanfattar året hittills och ger lästips inför sommaren.
-
AstraZeneca moves to brewery quarters in central Copenhagen
AstraZeneca in Denmark is moving its business into central Copenhagen and the old brewery quarters in Carlsberg Byen.
-
15 framtidsyrken inom life science: “Huggsexa om kompetens”
Arbetsmarknaden för naturvetare som jobbar med life science har mycket goda framtidsutsikter. Det visar en ny rapport från fackförbundet Naturvetarna.
-
Samuel Lagercrantz: The government’s performance in healthcare and life sciences so far
Since the change of government in Sweden, developments in the healthcare sector have shown promising signs, but the outlook in life sciences is less promising, writes Samuel Lagercrantz in an editorial.
-
Uncertainty about the government’s life science work
The government’s national coordinator for life science, Jenni Nordborg, left her position almost four months ago. No one has yet succeeded her, and now questions are being raised both about the government’s plans for the office and the Swedish life science strategy.
-
New diagnostic rules raise concerns
In a panel discussion, several voices from academia and the industry expressed concerns about the transition to the new regulatory framework for in-vitro diagnostics (IVDR). They argue that it may create significant differences between regions, and patients may be affected.
-
Hon ska ansvara för Gedeas kvalitetssäkring
Lundabolaget Gedea Biotech har utsett Anna-Karin Areskog till ny QA Director.
-
Kristdemokraterna rekryterar från Sanofi
Jonas Sareld, Public Affairs Manager vid Sanofi, blir kanslichef för Kristdemokraterna i Region Stockholm.
-
Meeting with focus on South Korea and Japan’s life sciences
Large, complex and exciting – this is how Britta Stenson, Business Sweden, describes the life science markets of Japan and South Korea, which took centre stage during a webcast seminar.
-
Major advances in IVF labs in the last few decades
Since the introduction of in vitro fertilisation several decades ago, many developments have been made in the field, and the main part of that development has taken place in the lab.
-
Sydkoreas och Japans life science i fokus på möte
Stora, komplexa och spännande. Så beskriver Britta Stenson, Business Sweden, Japans och Sydkoreas marknader för life science, som stod i centrum under ett webbsänt seminarium.
-
Stor kartläggning av svensk läkemedelsutveckling - "Väldigt imponerande bidrag"
Trots tuffa tider planerar två av tre life science-bolag att nyrekrytera – och antalet läkemedelsprojekt fortsätter att öka. Det visar branschorganisationen Sweden Bios stora kartläggning av svensk läkemedelsutveckling.
-
Editorial: ”AI that both impresses and frightens”
”In the past, I've rarely been particularly impressed by something that was produced by AI. But this is something completely different”, Samuel Lagercrantz writes in an editorial.
-
Rapid development in blood analysis – “Sweden is leading the race”
Thousands of analytical tests using just one single drop of blood. What was revealed as a hoax just a few years ago is now a reality, according to KTH professor and serial entrepreneur Mathias Uhlén.
-
God löneutveckling inom life science
Efterfrågan på arbetskraft inom life science ökar och ny statistik från Naturvetarna visar även på en god löneutveckling under fjolåret.
-
Läkemedel mot MLD rekommenderas av NT-rådet
Orchard Therapeutics läkemedel Libmeldy, mot metakromatisk leukodystrofi, rekommenderas nu av rådet för nya terapier i Sverige.
-
Dylan Ceynowa är ny medicinsk chef på Novocure
Cancerterapibolaget Novocure har rekryterat Dylan Ceynowa till tjänsten som Senior Medical Manager.
-
Kraftigt ökad läkemedelförsäljning – här är bolagen som sålde mest
Fjolåret bjöd på en kraftig försäljningsökning i Sverige för de största läkemedelsföretagen. Åtta av tio företag på tio i topp-listan ökade med mer än tio procent, visar en sammanställning.
-
“Everyone is screaming for talent”
Attracting talent is one of the life science industry’s major future challenges, which was one of the conclusions of the panel discussion that ended the New Horizons in Biologics & Bioprocessing conference on 15 December.
BREAKING